Ownership
Private
Employees
~813
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Carnot Laboratorios General Information
Carnot Laboratorios has over eight decades of experience developing and commercializing pharmaceutical products for Latin America. The company focuses on innovative medicines for common ailments across several therapeutic areas including gastroenterology and respiratory disease. It operates two production facilities in Mexico and exports to more than fifteen countries. Recent investments include a new state-of-the-art manufacturing plant in Hidalgo to expand capacity and global reach.[5] No recent clinical trial results are publicly highlighted.
Contact Information
Drug Pipeline
tegoprazan
CommercialKey Partnerships
Acerus Pharmaceuticals – licensing agreement for NATESTO® testosterone therapy covering Central & Latin America.
Carnot Laboratorios Funding
No funding data available
To view Carnot Laboratorios's complete valuation and funding history, request access »
Gosset